02 Oct HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes
Posted at 00:00h
in
Authored by: Hamers R. L., Zaaijer Hans, Wallis Carole L., Siwale Margaret, Ive Prudence, Botes Mariette E., Sigaloff Kim C., Hoepelman A. I. M., Stevens Wendy S., Rinke de Wit T. F., PharmAccess African Studies to Evaluate Resistance (PASER)
In: JAIDS Journal of Acquired Immune Deficiency Syndromes, 2013, 64(2):174-82. doi: 10.1097/QAI.0b013e3182a60f7d
http://www.ncbi.nlm.nih.gov/pubmed/23892239